DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED

DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED was reported 21652 times

DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 230 0.3443
1 VAGINAL FLATULENCE 95 0.3135
2 ALLERGY TO IMMUNOGLOBULIN THERAPY 34 0.3119
3 NEUROLOGIC NEGLECT SYNDROME 131 0.2356
4 BLOOD PRESSURE DIASTOLIC ABNORMAL 598 0.2349
5 BLOOD PRESSURE SYSTOLIC ABNORMAL 572 0.2312
6 SWOLLEN JOINT COUNT 57 0.2280
7 GRIP STRENGTH 50 0.2183
8 LUPUS VULGARIS 266 0.2111
9 RETINITIS 295 0.1706
10 INFUSION SITE DISCHARGE 296 0.1687
11 POST CHOLECYSTECTOMY SYNDROME 43 0.1519
12 CAROTID ARTERY THROMBOSIS 127 0.1496
13 SERONEGATIVE ARTHRITIS 152 0.1326
14 RED BLOOD CELL SEDIMENTATION RATE 35 0.1254
15 GRANULOCYTE COUNT INCREASED 50 0.1235
16 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 241 0.1162
17 ELECTRIC SHOCK 96 0.1120
18 DISLOCATION OF VERTEBRA 253 0.1108
19 DEEP VEIN THROMBOSIS POSTOPERATIVE 204 0.1018
20 INFUSION SITE MASS 109 0.1003
21 ADJUSTMENT DISORDER 124 0.0954
22 ALLERGY TO PLANTS 43 0.0941
23 INFUSION SITE BRUISING 192 0.0888
24 TEMPERATURE REGULATION DISORDER 197 0.0883
25 X-RAY ABNORMAL 157 0.0877
26 INFUSION SITE PRURITUS 267 0.0845
27 RHEUMATIC FEVER 365 0.0818
28 SWOLLEN JOINT COUNT INCREASED 256 0.0802
29 GRANULOMATOSIS WITH POLYANGIITIS 96 0.0795
30 BLOOD IMMUNOGLOBULIN A INCREASED 42 0.0779
31 DEATH NEONATAL 105 0.0754
32 BONE EROSION 266 0.0751
33 POSTMORTEM BLOOD DRUG LEVEL INCREASED 27 0.0724
34 INFUSION SITE HAEMORRHAGE 235 0.0714
35 INFUSION SITE URTICARIA 47 0.0701
36 RHEUMATOID FACTOR POSITIVE 398 0.0688
37 PORPHYRIA ACUTE 98 0.0683
38 INFUSION SITE SCAR 30 0.0677
39 BLOOD PRESSURE DIASTOLIC DECREASED 495 0.0670
40 CONGESTIVE HEPATOPATHY 28 0.0625
41 CHRONIC SINUSITIS 224 0.0596
42 ENDOMETRIAL DISORDER 24 0.0581
43 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 403 0.0562
44 INFUSION SITE RASH 77 0.0561
45 FEMALE GENITAL TRACT FISTULA 95 0.0556
46 DUODENAL ULCER PERFORATION 411 0.0552
47 MULTIPLE ALLERGIES 425 0.0542
48 GLOMERULAR FILTRATION RATE INCREASED 44 0.0533
49 VITAMIN B12 INCREASED 42 0.0527
50 INFUSION SITE SWELLING 327 0.0519
51 PHARYNGEAL PARAESTHESIA 82 0.0516
52 INTERVERTEBRAL DISCITIS 97 0.0514
53 PERSONALITY DISORDER 133 0.0507
54 FRACTURE PAIN 27 0.0501
55 FACET JOINT SYNDROME 163 0.0500
56 BLOOD PRESSURE SYSTOLIC INCREASED 957 0.0490
57 C-REACTIVE PROTEIN 45 0.0485
58 INFUSION SITE DISCOMFORT 50 0.0482
59 ALLERGIC SINUSITIS 41 0.0478
60 DACTYLITIS 45 0.0458
61 C-REACTIVE PROTEIN ABNORMAL 292 0.0455
62 DEVICE INFUSION ISSUE 112 0.0451
63 RHEUMATOID FACTOR INCREASED 50 0.0448
64 HELICOBACTER INFECTION 456 0.0443
65 PEMPHIGUS 550 0.0439
66 INSURANCE ISSUE 665 0.0434
67 INCORRECT DRUG ADMINISTRATION RATE 183 0.0430
68 INFUSION RELATED REACTION 2827 0.0426
69 BLOOD PRESSURE FLUCTUATION 1013 0.0422
70 HYPERCHOLESTEROLAEMIA 407 0.0421
71 GRANULOMA SKIN 34 0.0414
72 EAR PRURITUS 144 0.0410
73 BLOOD PRESSURE DIASTOLIC INCREASED 189 0.0409
74 PERIPHERAL VENOUS DISEASE 166 0.0406
75 RADICULOPATHY 107 0.0406
76 SEASONAL ALLERGY 569 0.0402
77 RED BLOOD CELL SEDIMENTATION RATE INCREASED 441 0.0398
78 MACULAR DEGENERATION 475 0.0397
79 ANTICHOLINERGIC SYNDROME 63 0.0395
80 SOFT TISSUE DISORDER 43 0.0388
81 RHEUMATOID LUNG 37 0.0387
82 INFECTED BITE 32 0.0377
83 MUSCLE INJURY 309 0.0373
84 INFUSION SITE ERYTHEMA 314 0.0372
85 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 241 0.0371
86 ENTEROCOCCUS TEST POSITIVE 24 0.0370
87 DRUG TOLERANCE DECREASED 103 0.0366
88 WOUND INFECTION 401 0.0366
89 INFUSION SITE PAIN 471 0.0365
90 HAND DEFORMITY 478 0.0364
91 FOOD ALLERGY 279 0.0361
92 INFUSION SITE IRRITATION 46 0.0358
93 PROCTITIS 98 0.0350
94 IMMUNISATION REACTION 25 0.0347
95 BURSITIS 419 0.0345
96 SMEAR CERVIX ABNORMAL 49 0.0345
97 SINUSITIS BACTERIAL 36 0.0342
98 WHITE BLOOD CELLS URINE POSITIVE 64 0.0340
99 INFUSION SITE OEDEMA 28 0.0335
100 VEIN RUPTURE 56 0.0334
101 POOR VENOUS ACCESS 341 0.0329
102 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 24 0.0327
103 INFUSION SITE WARMTH 40 0.0326
104 VEIN COLLAPSE 25 0.0326
105 ORAL PRURITUS 74 0.0322
106 PSEUDOMONAL BACTERAEMIA 27 0.0316
107 ALLERGY TO CHEMICALS 39 0.0313
108 FOOT DEFORMITY 339 0.0306
109 SPONDYLITIS 111 0.0305
110 GRIP STRENGTH DECREASED 268 0.0304
111 JOINT RANGE OF MOTION DECREASED 404 0.0301
112 LOWER RESPIRATORY TRACT CONGESTION 51 0.0300
113 FOLLICULITIS 313 0.0298
114 INFUSION SITE REACTION 89 0.0298
115 SYNOVITIS 535 0.0296
116 BODY TEMPERATURE DECREASED 291 0.0295
117 EXOSTOSIS 269 0.0294
118 WALKING AID USER 193 0.0292
119 AUTOIMMUNE DISORDER 284 0.0291
120 JOINT DISLOCATION 306 0.0289
121 OBSTRUCTION 115 0.0288
122 PERICARDITIS 479 0.0285
123 INFUSION SITE DISCOLOURATION 25 0.0284
124 EAR INFECTION 744 0.0279
125 LUPUS-LIKE SYNDROME 252 0.0278
126 GANGRENE 167 0.0277
127 INFUSION SITE EXTRAVASATION 172 0.0276
128 POST-ACUTE COVID-19 SYNDROME 34 0.0274
129 BONE CONTUSION 25 0.0273
130 TENOSYNOVITIS 75 0.0272
131 NOROVIRUS INFECTION 39 0.0270
132 DUST ALLERGY 26 0.0265
133 JOINT NOISE 52 0.0264
134 ALLERGY TO ANIMAL 28 0.0263
135 ASPARTATE AMINOTRANSFERASE ABNORMAL 40 0.0262
136 BREAST CANCER STAGE III 166 0.0256
137 SINUS CONGESTION 338 0.0250
138 BLOOD PARATHYROID HORMONE DECREASED 37 0.0249
139 ENTHESOPATHY 39 0.0249
140 RHEUMATOID NODULE 68 0.0247
141 DEMYELINATION 100 0.0244
142 ARTERIAL OCCLUSIVE DISEASE 191 0.0243
143 UPPER RESPIRATORY TRACT INFECTION 1121 0.0242
144 IMMUNOGLOBULINS DECREASED 33 0.0240
145 MONOCYTE COUNT INCREASED 87 0.0239
146 HEART RATE DECREASED 828 0.0236
147 DERMATITIS CONTACT 267 0.0234
148 FIBROMYALGIA 565 0.0232
149 JOINT DESTRUCTION 36 0.0231
150 BLOOD PRESSURE SYSTOLIC DECREASED 105 0.0231
151 GASTROINTESTINAL VIRAL INFECTION 24 0.0231
152 SINUSITIS 2333 0.0227
153 BLOOD IMMUNOGLOBULIN G DECREASED 56 0.0226
154 NEUROMYELITIS OPTICA SPECTRUM DISORDER 30 0.0222
155 SKIN LACERATION 238 0.0219
156 ARTHROPOD STING 36 0.0216
157 SCIATICA 342 0.0214
158 PRODUCT DISTRIBUTION ISSUE 196 0.0211
159 RESPIRATORY TRACT INFECTION 547 0.0210
160 COELIAC DISEASE 205 0.0209
161 WEIGHT FLUCTUATION 216 0.0206
162 OXYGEN SATURATION DECREASED 1152 0.0205
163 IRRITABLE BOWEL SYNDROME 436 0.0203
164 SKIN ABRASION 96 0.0203
165 GLOSSODYNIA 453 0.0202
166 IMMUNODEFICIENCY 301 0.0202
167 EXPOSURE TO SARS-COV-2 34 0.0200
168 WOUND 558 0.0199
169 RESPIRATORY RATE INCREASED 176 0.0198
170 SINUS PAIN 46 0.0197
171 LIP DRY 179 0.0197
172 BODY TEMPERATURE ABNORMAL 36 0.0195
173 SENSORY LOSS 157 0.0195
174 RHEUMATOID ARTHRITIS 2207 0.0194
175 PULMONARY FIBROSIS 365 0.0190
176 SPINAL FUSION SURGERY 76 0.0187
177 LIMB MASS 41 0.0187
178 PANNICULITIS 45 0.0186
179 ALANINE AMINOTRANSFERASE ABNORMAL 39 0.0185
180 TYMPANIC MEMBRANE PERFORATION 31 0.0183
181 PNEUMONIA VIRAL 58 0.0182
182 SINUS DISORDER 355 0.0179
183 OXYGEN SATURATION ABNORMAL 50 0.0176
184 INFUSION SITE INDURATION 26 0.0175
185 FOETAL DEATH 91 0.0175
186 JOINT STIFFNESS 457 0.0174
187 TYPE 2 DIABETES MELLITUS 581 0.0172
188 C-REACTIVE PROTEIN INCREASED 623 0.0171
189 LIMB DEFORMITY 27 0.0170
190 SUSPECTED COVID-19 56 0.0170
191 VASCULAR RUPTURE 26 0.0168
192 COORDINATION ABNORMAL 234 0.0168
193 RESPIRATORY TRACT INFECTION VIRAL 39 0.0167
194 LUPUS NEPHRITIS 31 0.0166
195 RESPIRATORY TRACT CONGESTION 262 0.0165
196 CONTRAINDICATED PRODUCT ADMINISTERED 499 0.0165
197 POST-TRAUMATIC STRESS DISORDER 110 0.0164
198 HEMIPLEGIA 136 0.0163
199 MUSCLE SPASTICITY 200 0.0163
200 HIP ARTHROPLASTY 248 0.0162
201 IMPAIRED HEALING 531 0.0162
202 CREPITATIONS 48 0.0161
203 JOINT EFFUSION 109 0.0158
204 PRESCRIBED OVERDOSE 303 0.0156
205 TOOTH INFECTION 206 0.0156
206 GASTROENTERITIS VIRAL 282 0.0156
207 SYSTEMIC LUPUS ERYTHEMATOSUS 554 0.0156
208 ARTHROPATHY 865 0.0155
209 BRONCHITIS 1143 0.0154
210 PHARYNGITIS STREPTOCOCCAL 167 0.0154
211 GASTROINTESTINAL TOXICITY 74 0.0154
212 CONTRAST MEDIA ALLERGY 28 0.0153
213 HEPATIC CIRRHOSIS 286 0.0152
214 LIVER INJURY 372 0.0151
215 PARANASAL SINUS DISCOMFORT 57 0.0150
216 HORDEOLUM 64 0.0148
217 LOWER LIMB FRACTURE 283 0.0147
218 THROAT IRRITATION 653 0.0145
219 ULCER 231 0.0145
220 TENDERNESS 148 0.0142
221 CONGENITAL ANOMALY 109 0.0141
222 CYSTITIS 448 0.0141
223 MIDDLE EAR EFFUSION 31 0.0140
224 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 115 0.0139
225 SKIN INFECTION 156 0.0139
226 PARAESTHESIA ORAL 200 0.0139
227 AFFECT LABILITY 133 0.0138
228 DERMATOMYOSITIS 35 0.0138
229 VIRAL UPPER RESPIRATORY TRACT INFECTION 65 0.0137
230 STREPTOCOCCAL INFECTION 76 0.0136
231 MOTOR DYSFUNCTION 138 0.0135
232 ANIMAL BITE 36 0.0135
233 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 30 0.0134
234 LOCALISED INFECTION 324 0.0134
235 VEIN DISORDER 67 0.0134
236 NASOPHARYNGITIS 2451 0.0133
237 ORAL CANDIDIASIS 175 0.0133
238 PHARYNGEAL DISORDER 38 0.0132
239 EYE INFECTION 149 0.0132
240 MYELOPATHY 25 0.0132
241 ORAL INFECTION 51 0.0130
242 OSTEOARTHRITIS 553 0.0130
243 ENDODONTIC PROCEDURE 33 0.0130
244 VASCULAR DEVICE INFECTION 59 0.0130
245 GASTROINTESTINAL INFECTION 116 0.0129
246 ADRENAL INSUFFICIENCY 157 0.0129
247 TOOTH ABSCESS 131 0.0129
248 JOINT INJURY 274 0.0128
249 THROAT CLEARING 48 0.0128
250 EYE CONTUSION 27 0.0128
251 JOINT SWELLING 1538 0.0127
252 COVID-19 PNEUMONIA 149 0.0126
253 OSTEOPOROSIS 518 0.0126
254 HEPATIC ENZYME INCREASED 853 0.0125
255 WEIGHT ABNORMAL 30 0.0125
256 INTENTIONAL PRODUCT USE ISSUE 1089 0.0124
257 ARTHROPOD BITE 92 0.0124
258 BLOOD PRESSURE INCREASED 1894 0.0124
259 VITAMIN B12 DEFICIENCY 50 0.0123
260 KIDNEY INFECTION 241 0.0123
261 THERAPEUTIC PRODUCT EFFECT DECREASED 550 0.0123
262 ARTHRITIS 963 0.0122
263 BLOOD CHOLESTEROL INCREASED 564 0.0121
264 BODY TEMPERATURE INCREASED 246 0.0120
265 RED CELL DISTRIBUTION WIDTH INCREASED 50 0.0120
266 PRESCRIBED UNDERDOSE 240 0.0120
267 VIRAL INFECTION 400 0.0120
268 KNEE ARTHROPLASTY 253 0.0120
269 CATHETER SITE PAIN 31 0.0119
270 GRANULOMA 41 0.0118
271 POST PROCEDURAL INFECTION 96 0.0118
272 SUSPECTED OFF LABEL USE 53 0.0117
273 CLUMSINESS 32 0.0117
274 LOWER RESPIRATORY TRACT INFECTION 530 0.0116
275 FINGER DEFORMITY 56 0.0115
276 UPPER-AIRWAY COUGH SYNDROME 94 0.0114
277 FIBROSIS 35 0.0114
278 TOOTH DISORDER 252 0.0113
279 BRONCHIECTASIS 76 0.0113
280 VASCULITIS 131 0.0112
281 POSTOPERATIVE WOUND INFECTION 75 0.0111
282 RHINITIS 89 0.0110
283 FOOD POISONING 59 0.0110
284 TEMPERATURE INTOLERANCE 113 0.0109
285 MATERNAL EXPOSURE TIMING UNSPECIFIED 41 0.0109
286 OTITIS MEDIA 36 0.0109
287 SNEEZING 244 0.0109
288 MUSCULOSKELETAL STIFFNESS 953 0.0109
289 EAR PAIN 211 0.0108
290 ONYCHOMYCOSIS 47 0.0107
291 EAR DISORDER 49 0.0107
292 LIP BLISTER 29 0.0106
293 PHARYNGITIS 132 0.0106
294 PROTEIN URINE PRESENT 53 0.0106
295 PULMONARY TOXICITY 75 0.0106
296 PSORIATIC ARTHROPATHY 428 0.0105
297 PRODUCTIVE COUGH 503 0.0105
298 ROAD TRAFFIC ACCIDENT 440 0.0105
299 VAGINAL DISCHARGE 104 0.0103
300 PULMONARY PAIN 30 0.0103
301 SPINAL DISORDER 97 0.0102
302 HAEMATOLOGICAL INFECTION 25 0.0102
303 LYME DISEASE 34 0.0102
304 DERMAL CYST 25 0.0102
305 RALES 59 0.0101
306 COVID-19 1780 0.0101
307 RESPIRATORY SYNCYTIAL VIRUS INFECTION 88 0.0101
308 VITAMIN B12 DECREASED 29 0.0101
309 APHTHOUS ULCER 78 0.0100
310 ATYPICAL PNEUMONIA 30 0.0100
311 DELIRIUM 348 0.0100
312 LIGAMENT SPRAIN 99 0.0100
313 GINGIVITIS 54 0.0100
314 INFECTION 1447 0.0100
315 SKIN HAEMORRHAGE 147 0.0099
316 EATING DISORDER 211 0.0099
317 CATARACT 586 0.0098
318 INTERVERTEBRAL DISC DEGENERATION 91 0.0098
319 IRON DEFICIENCY 44 0.0098
320 SYNOVIAL CYST 45 0.0097
321 BREATH SOUNDS ABNORMAL 48 0.0097
322 INFLUENZA 1084 0.0097
323 DRUG TOLERANCE 49 0.0097
324 TONGUE DISORDER 70 0.0097
325 INFLAMMATION 485 0.0094
326 NERVE COMPRESSION 86 0.0093
327 DISCOMFORT 567 0.0093
328 BLISTER 520 0.0092
329 SINUS HEADACHE 55 0.0092
330 PARANASAL SINUS HYPERSECRETION 35 0.0092
331 OBESITY 146 0.0092
332 PHARYNGEAL SWELLING 89 0.0091
333 NEURALGIA 221 0.0091
334 BLOOD URIC ACID INCREASED 52 0.0090
335 FOOT FRACTURE 170 0.0090
336 HERPES ZOSTER 513 0.0089
337 SARCOIDOSIS 42 0.0088
338 PROCEDURAL PAIN 245 0.0088
339 LIMB INJURY 239 0.0088
340 HEART RATE ABNORMAL 49 0.0088
341 RHINITIS ALLERGIC 39 0.0088
342 NEUTROPHIL COUNT INCREASED 89 0.0087
343 SKIN NECROSIS 45 0.0087
344 LIVER FUNCTION TEST INCREASED 185 0.0086
345 FREQUENT BOWEL MOVEMENTS 231 0.0085
346 BLOOD PRESSURE ABNORMAL 170 0.0085
347 CONCUSSION 66 0.0085
348 HEMIPARESIS 144 0.0085
349 WHEEZING 502 0.0085
350 DIVERTICULITIS 234 0.0084
351 GASTRIC INFECTION 32 0.0084
352 ILLNESS 861 0.0083
353 RESPIRATORY DISORDER 249 0.0083
354 BLOOD CREATININE DECREASED 26 0.0083
355 BONE DENSITY ABNORMAL 31 0.0083
356 SLEEP APNOEA SYNDROME 158 0.0083
357 HEART RATE INCREASED 817 0.0082
358 DRUG INTOLERANCE 794 0.0082
359 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 42 0.0082
360 ARTHRITIS INFECTIVE 38 0.0082
361 FACE INJURY 31 0.0082
362 CONTUSION 783 0.0081
363 CHOLECYSTITIS ACUTE 46 0.0081
364 PNEUMONIA FUNGAL 32 0.0081
365 ILL-DEFINED DISORDER 492 0.0081
366 LUNG DISORDER 393 0.0080
367 MENINGITIS ASEPTIC 36 0.0080
368 CANDIDA INFECTION 135 0.0080
369 TONGUE ULCERATION 27 0.0080
370 RHINOVIRUS INFECTION 31 0.0080
371 NASAL CONGESTION 467 0.0079
372 PSEUDOMONAS INFECTION 68 0.0079
373 RHINORRHOEA 512 0.0079
374 SWELLING 739 0.0079
375 TOXICITY TO VARIOUS AGENTS 1331 0.0079
376 ASTHMA 886 0.0078
377 WEIGHT INCREASED 1754 0.0078
378 MICTURITION DISORDER 27 0.0078
379 OEDEMA 421 0.0078
380 BASAL CELL CARCINOMA 121 0.0077
381 OROPHARYNGEAL PAIN 711 0.0077
382 MYASTHENIA GRAVIS 62 0.0077
383 GAIT INABILITY 255 0.0076
384 MOBILITY DECREASED 548 0.0076
385 ANGINA PECTORIS 218 0.0076
386 HEREDITARY ANGIOEDEMA 81 0.0075
387 NIGHT SWEATS 243 0.0075
388 MUSCULOSKELETAL PAIN 395 0.0075
389 PERIPHERAL SWELLING 1155 0.0075
390 GASTROINTESTINAL DISORDER 665 0.0074
391 PNEUMONIA BACTERIAL 68 0.0074
392 HYPERTENSION 1562 0.0074
393 PNEUMONIA 2387 0.0074
394 TOOTH FRACTURE 81 0.0073
395 SPUTUM DISCOLOURED 69 0.0073
396 STOMATITIS 441 0.0073
397 ABDOMINAL HERNIA 33 0.0072
398 FUNGAL INFECTION 240 0.0072
399 SKIN ULCER 186 0.0072
400 THERAPY NON-RESPONDER 323 0.0072
401 CAROTID ARTERY STENOSIS 25 0.0072
402 URINARY TRACT INFECTION 1213 0.0071
403 JAUNDICE CHOLESTATIC 25 0.0071
404 HYPOMANIA 26 0.0071
405 WEIGHT DECREASED 1969 0.0070
406 PULMONARY MASS 105 0.0070
407 RASH ERYTHEMATOUS 334 0.0070
408 DRY THROAT 71 0.0070
409 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1253 0.0069
410 DECREASED IMMUNE RESPONSIVENESS 68 0.0069
411 MIGRAINE 658 0.0069
412 TREATMENT FAILURE 571 0.0069
413 APHONIA 96 0.0069
414 COUGH 1919 0.0068
415 PHLEBITIS 35 0.0068
416 DISABILITY 135 0.0068
417 CLAVICLE FRACTURE 26 0.0068
418 NODULE 88 0.0067
419 HYPERSENSITIVITY 1251 0.0067
420 MUSCULAR WEAKNESS 765 0.0067
421 INJURY 473 0.0067
422 NASAL POLYPS 33 0.0067
423 FUNGAL SKIN INFECTION 27 0.0067
424 TOOTHACHE 121 0.0067
425 WHITE BLOOD CELL COUNT INCREASED 255 0.0066
426 ARTHRALGIA 2756 0.0066
427 THERMAL BURN 47 0.0066
428 BACTERIAL INFECTION 123 0.0066
429 HAEMATOCRIT DECREASED 130 0.0065
430 ROTATOR CUFF SYNDROME 84 0.0065
431 DENTAL CARIES 72 0.0065
432 INJECTION SITE DISCHARGE 35 0.0065
433 ORAL HERPES 127 0.0065
434 VITAMIN D DEFICIENCY 63 0.0065
435 LIVE BIRTH 54 0.0064
436 MUSCULOSKELETAL DISCOMFORT 111 0.0064
437 FEAR OF INJECTION 46 0.0064
438 MASS 90 0.0064
439 UPPER LIMB FRACTURE 128 0.0064
440 INJECTION SITE EXTRAVASATION 79 0.0064
441 URINE ABNORMALITY 29 0.0064
442 SCRATCH 67 0.0063
443 MENISCUS INJURY 39 0.0063
444 SCAR 108 0.0063
445 DRUG ABUSE 524 0.0063
446 CELLULITIS 317 0.0063
447 FLUID RETENTION 319 0.0063
448 INFLUENZA LIKE ILLNESS 516 0.0063
449 BREAST CANCER STAGE II 52 0.0062
450 MUSCLE STRAIN 54 0.0062
451 MUSCULOSKELETAL CHEST PAIN 96 0.0062
452 RIB FRACTURE 127 0.0062
453 WRIST FRACTURE 74 0.0062
454 RECTAL HAEMORRHAGE 265 0.0062
455 HYPERKERATOSIS 34 0.0062
456 PULMONARY CONGESTION 81 0.0061
457 MENINGITIS 41 0.0061
458 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 435 0.0061
459 RED BLOOD CELL COUNT DECREASED 174 0.0061
460 MOUTH ULCERATION 126 0.0060
461 SENSITIVE SKIN 44 0.0060
462 SCAB 68 0.0060
463 DRY MOUTH 483 0.0059
464 BLOOD URINE PRESENT 113 0.0059
465 EAR DISCOMFORT 61 0.0059
466 LYMPHOCYTE COUNT DECREASED 105 0.0059
467 CHEST DISCOMFORT 608 0.0059
468 HAND FRACTURE 42 0.0059
469 PRE-EXISTING CONDITION IMPROVED 37 0.0059
470 BLOOD TEST ABNORMAL 83 0.0059
471 ESCHERICHIA URINARY TRACT INFECTION 25 0.0059
472 PRODUCT USE ISSUE 1104 0.0059
473 MIOSIS 47 0.0059
474 PERIORBITAL SWELLING 33 0.0058
475 CONJUNCTIVITIS 108 0.0058
476 LYMPHOEDEMA 40 0.0058
477 HEPATOTOXICITY 128 0.0057
478 HERNIA 111 0.0057
479 PRODUCT DOSE OMISSION ISSUE 1686 0.0057
480 THERAPEUTIC RESPONSE DECREASED 347 0.0057
481 ESCHERICHIA INFECTION 47 0.0057
482 URTICARIA 955 0.0057
483 HAEMOGLOBIN INCREASED 26 0.0057
484 SPINAL OSTEOARTHRITIS 50 0.0057
485 MUSCULOSKELETAL DISORDER 108 0.0057
486 LIVER DISORDER 251 0.0057
487 LIGAMENT RUPTURE 25 0.0057
488 DRUG-INDUCED LIVER INJURY 177 0.0056
489 TACHYCARDIA 497 0.0056
490 ABDOMINAL DISCOMFORT 937 0.0056
491 BRAIN FOG 87 0.0055
492 RENAL CYST 44 0.0055
493 HYPOAESTHESIA 829 0.0055
494 COLITIS ULCERATIVE 247 0.0055
495 TYPE 1 DIABETES MELLITUS 33 0.0055
496 DYSPEPSIA 539 0.0055
497 BLOOD IRON DECREASED 65 0.0055
498 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 93 0.0055
499 PYREXIA 1885 0.0054
500 INTERVERTEBRAL DISC PROTRUSION 119 0.0054
501 BACK DISORDER 88 0.0054
502 PREGNANCY 108 0.0054
503 MYDRIASIS 69 0.0054
504 GENERAL PHYSICAL HEALTH DETERIORATION 622 0.0054
505 SARS-COV-2 TEST POSITIVE 71 0.0054
506 ROSACEA 25 0.0054
507 POST PROCEDURAL COMPLICATION 103 0.0054
508 BODY HEIGHT DECREASED 57 0.0053
509 SCOLIOSIS 33 0.0053
510 CARDIAC MURMUR 46 0.0053
511 DYSARTHRIA 199 0.0053
512 HEART RATE IRREGULAR 119 0.0053
513 PELVIC FRACTURE 41 0.0053
514 NEPHROLITHIASIS 241 0.0052
515 ANAL FISTULA 28 0.0052
516 IMMUNE THROMBOCYTOPENIA 24 0.0052
517 BACK PAIN 1216 0.0052
518 BREAST MASS 35 0.0052
519 PAIN 3193 0.0052
520 FEELING HOT 317 0.0052
521 APHASIA 156 0.0052
522 HYPOTENSION 1036 0.0052
523 DYSPHAGIA 490 0.0052
524 EXPOSURE DURING PREGNANCY 320 0.0051
525 HEADACHE 3206 0.0051
526 BLOOD MAGNESIUM DECREASED 44 0.0051
527 OEDEMA PERIPHERAL 615 0.0050
528 PRODUCT SUPPLY ISSUE 36 0.0050
529 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 241 0.0050
530 SLEEP DISORDER 353 0.0050
531 BACK INJURY 54 0.0050
532 COLITIS 188 0.0050
533 ABSCESS 79 0.0049
534 NECK PAIN 274 0.0049
535 POLYP 32 0.0049
536 IMMUNOSUPPRESSION 43 0.0049
537 PAIN IN EXTREMITY 1433 0.0049
538 OSTEOMYELITIS 88 0.0049
539 HYPERVOLAEMIA 24 0.0049
540 MATERNAL EXPOSURE DURING PREGNANCY 425 0.0048
541 HYPERTRANSAMINASAEMIA 33 0.0047
542 HEAD INJURY 150 0.0047
543 ULCER HAEMORRHAGE 32 0.0047
544 ERYTHEMA 965 0.0047
545 CYST 58 0.0047
546 DYSPNOEA EXERTIONAL 176 0.0047
547 COMPRESSION FRACTURE 25 0.0047
548 EMPHYSEMA 47 0.0047
549 FALL 1549 0.0046
550 GALLBLADDER DISORDER 83 0.0046
551 OROPHARYNGEAL DISCOMFORT 42 0.0046
552 ANGIOPATHY 26 0.0046
553 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 241 0.0046
554 FATIGUE 3588 0.0046
555 BLEPHAROSPASM 29 0.0046
556 PLATELET COUNT INCREASED 60 0.0046
557 COMPLETED SUICIDE 383 0.0046
558 BLOOD PRESSURE DECREASED 305 0.0046
559 NEUTROPHIL COUNT DECREASED 187 0.0046
560 ANKLE FRACTURE 71 0.0046
561 CARPAL TUNNEL SYNDROME 64 0.0046
562 DEVICE OCCLUSION 64 0.0045
563 BREAST CANCER STAGE I 42 0.0045
564 BLADDER DISORDER 45 0.0045
565 TENDONITIS 70 0.0045
566 ORAL DISORDER 33 0.0045
567 MALAISE 1966 0.0045
568 IMPAIRED GASTRIC EMPTYING 61 0.0045
569 NASAL DRYNESS 28 0.0045
570 BLOOD POTASSIUM DECREASED 134 0.0045
571 BLOOD UREA INCREASED 74 0.0044
572 SKIN CANCER 94 0.0044
573 AMNESIA 284 0.0044
574 THROAT TIGHTNESS 118 0.0044
575 PALPITATIONS 510 0.0044
576 PULMONARY THROMBOSIS 47 0.0043
577 RESTLESS LEGS SYNDROME 77 0.0042
578 CLOSTRIDIUM DIFFICILE INFECTION 92 0.0042
579 HIATUS HERNIA 54 0.0042
580 CHILLS 487 0.0042
581 STAPHYLOCOCCAL INFECTION 137 0.0041
582 PERIPHERAL COLDNESS 57 0.0041
583 FACIAL PAIN 37 0.0041
584 GASTRIC DISORDER 142 0.0041
585 INCREASED TENDENCY TO BRUISE 38 0.0041
586 THYROID DISORDER 62 0.0040
587 DRY EYE 200 0.0040
588 FEELING COLD 111 0.0040
589 EYE INFLAMMATION 38 0.0040
590 CHEST PAIN 734 0.0040
591 BONE DISORDER 72 0.0039
592 HYPERHIDROSIS 509 0.0039
593 FLANK PAIN 37 0.0039
594 INTENTIONAL OVERDOSE 253 0.0039
595 RASH 1706 0.0039
596 GASTROENTERITIS 57 0.0039
597 COMPLICATION ASSOCIATED WITH DEVICE 56 0.0039
598 EYE DISCHARGE 40 0.0038
599 NEEDLE ISSUE 112 0.0038
600 GASTROOESOPHAGEAL REFLUX DISEASE 309 0.0038
601 SKIN FISSURES 75 0.0038
602 MEDICATION ERROR 213 0.0038
603 ANXIETY 1090 0.0038
604 FLUSHING 389 0.0038
605 MYOPATHY 33 0.0038
606 PRODUCT USE IN UNAPPROVED INDICATION 938 0.0038
607 ANAPHYLACTIC REACTION 209 0.0038
608 RASH PRURITIC 205 0.0038
609 HYPOAESTHESIA ORAL 57 0.0038
610 DECREASED APPETITE 874 0.0038
611 VISUAL IMPAIRMENT 466 0.0038
612 HEPATIC STEATOSIS 70 0.0038
613 BLOOD DISORDER 30 0.0037
614 CONFUSIONAL STATE 605 0.0037
615 THERAPEUTIC RESPONSE SHORTENED 124 0.0037
616 GOUT 67 0.0037
617 INABILITY TO AFFORD MEDICATION 37 0.0037
618 OFF LABEL USE 3241 0.0037
619 SPINAL FRACTURE 74 0.0037
620 NEUROPATHY PERIPHERAL 351 0.0037
621 PRODUCT AVAILABILITY ISSUE 84 0.0037
622 UROSEPSIS 34 0.0037
623 COGNITIVE DISORDER 172 0.0037
624 AORTIC ANEURYSM 28 0.0037
625 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 63 0.0037
626 POOR QUALITY SLEEP 79 0.0037
627 PROCEDURAL COMPLICATION 28 0.0036
628 GENERALISED OEDEMA 45 0.0036
629 HEAD DISCOMFORT 64 0.0036
630 RETCHING 77 0.0036
631 BALANCE DISORDER 311 0.0036
632 PSORIASIS 467 0.0036
633 PRURITUS 1371 0.0036
634 EYE DISORDER 117 0.0036
635 BLOOD ALKALINE PHOSPHATASE INCREASED 88 0.0035
636 SOMNOLENCE 713 0.0035
637 NEPHROPATHY 33 0.0035
638 NAUSEA 2782 0.0035
639 ALOPECIA 690 0.0035
640 IMMUNE SYSTEM DISORDER 46 0.0035
641 RENAL PAIN 37 0.0035
642 ASPIRATION 38 0.0035
643 SUPRAVENTRICULAR TACHYCARDIA 33 0.0034
644 CHOLELITHIASIS 113 0.0034
645 SMALL INTESTINAL OBSTRUCTION 42 0.0034
646 FURUNCLE 27 0.0034
647 BLOOD ALBUMIN DECREASED 27 0.0034
648 BLOOD CREATININE INCREASED 222 0.0034
649 CEREBRAL DISORDER 25 0.0034
650 MEMORY IMPAIRMENT 463 0.0034
651 WHITE BLOOD CELL COUNT DECREASED 365 0.0034
652 PYELONEPHRITIS 29 0.0033
653 ABDOMINAL PAIN 778 0.0033
654 MYOSITIS 30 0.0033
655 HYPERCALCAEMIA 41 0.0033
656 PRODUCT DOSE OMISSION IN ERROR 94 0.0033
657 NAIL DISORDER 29 0.0033
658 ATELECTASIS 32 0.0033
659 OVARIAN CYST 33 0.0033
660 SKIN DISORDER 110 0.0033
661 HAEMOGLOBIN DECREASED 338 0.0033
662 DYSPNOEA 1863 0.0033
663 ABDOMINAL PAIN UPPER 677 0.0033
664 PSYCHOTIC DISORDER 97 0.0033
665 LACRIMATION INCREASED 99 0.0033
666 VITAMIN D DECREASED 28 0.0033
667 SECRETION DISCHARGE 41 0.0033
668 MULTIPLE SCLEROSIS 156 0.0033
669 FEELING JITTERY 62 0.0033
670 SINUS TACHYCARDIA 46 0.0032
671 LEUKOPENIA 162 0.0032
672 COLD SWEAT 57 0.0032
673 GLAUCOMA 62 0.0032
674 NEOPLASM 37 0.0032
675 APPENDICITIS 30 0.0032
676 OCULAR DISCOMFORT 36 0.0032
677 INTENTIONAL DOSE OMISSION 91 0.0032
678 VOMITING 1500 0.0032
679 VENTRICULAR EXTRASYSTOLES 33 0.0032
680 HAEMATOCHEZIA 175 0.0032
681 LIMB DISCOMFORT 98 0.0032
682 DEPRESSION 717 0.0031
683 ALANINE AMINOTRANSFERASE INCREASED 193 0.0031
684 DEPRESSED MOOD 166 0.0031
685 PHOTOPHOBIA 59 0.0031
686 SKIN REACTION 44 0.0031
687 LABORATORY TEST ABNORMAL 92 0.0031
688 HYSTERECTOMY 27 0.0031
689 ADVERSE EVENT 287 0.0031
690 ANAL INCONTINENCE 28 0.0031
691 BLOOD BILIRUBIN INCREASED 84 0.0031
692 NEOPLASM MALIGNANT 207 0.0031
693 FEMUR FRACTURE 96 0.0031
694 HAEMOPTYSIS 86 0.0031
695 ASTHENIA 1158 0.0031
696 DIZZINESS 1529 0.0031
697 DEVICE RELATED INFECTION 47 0.0031
698 PROTEINURIA 58 0.0030
699 ORAL PAIN 68 0.0030
700 HOT FLUSH 228 0.0030
701 CHOKING 59 0.0030
702 SPINAL COMPRESSION FRACTURE 25 0.0030
703 RESPIRATORY DEPRESSION 37 0.0030
704 GINGIVAL PAIN 24 0.0030
705 PALLOR 82 0.0030
706 GAIT DISTURBANCE 575 0.0030
707 CONSTIPATION 655 0.0030
708 SKIN DISCOLOURATION 138 0.0030
709 DRUG ERUPTION 53 0.0030
710 INSOMNIA 796 0.0030
711 ADVERSE DRUG REACTION 268 0.0030
712 INCREASED APPETITE 57 0.0030
713 TASTE DISORDER 60 0.0030
714 SYNCOPE 294 0.0029
715 LYMPHADENOPATHY 104 0.0029
716 HIP FRACTURE 94 0.0029
717 URINARY RETENTION 97 0.0029
718 VERTIGO 177 0.0029
719 PARALYSIS 41 0.0029
720 GASTRITIS 75 0.0028
721 VENTRICULAR TACHYCARDIA 47 0.0028
722 BLOOD SODIUM DECREASED 53 0.0028
723 CONDITION AGGRAVATED 853 0.0028
724 EYE PAIN 158 0.0028
725 HYPOXIA 98 0.0028
726 EYE SWELLING 103 0.0028
727 ARTERIOSCLEROSIS 26 0.0028
728 MUSCLE SPASMS 505 0.0027
729 PULMONARY OEDEMA 123 0.0027
730 RASH MACULAR 96 0.0027
731 AGITATION 201 0.0027
732 ABDOMINAL DISTENSION 285 0.0027
733 ASPARTATE AMINOTRANSFERASE INCREASED 145 0.0027
734 LYMPHOMA 42 0.0027
735 THERAPY PARTIAL RESPONDER 42 0.0027
736 BRAIN OEDEMA 34 0.0027
737 DYSURIA 99 0.0027
738 PNEUMOCYSTIS JIROVECII PNEUMONIA 27 0.0027
739 INTENTIONAL PRODUCT MISUSE 235 0.0027
740 DIARRHOEA 1730 0.0027
741 PANCREATITIS 141 0.0027
742 MUSCLE TIGHTNESS 43 0.0027
743 TOOTH EXTRACTION 33 0.0026
744 PARAESTHESIA 416 0.0026
745 NERVOUSNESS 138 0.0026
746 DEHYDRATION 350 0.0026
747 MALIGNANT MELANOMA 35 0.0026
748 MUSCLE TWITCHING 60 0.0026
749 UNRESPONSIVE TO STIMULI 67 0.0026
750 PNEUMOTHORAX 41 0.0026
751 INTERSTITIAL LUNG DISEASE 125 0.0026
752 CARDIAC DISORDER 241 0.0026
753 BURNING SENSATION 180 0.0026
754 EPISTAXIS 192 0.0026
755 EYELID PTOSIS 26 0.0026
756 SLUGGISHNESS 26 0.0025
757 HEPATOMEGALY 25 0.0025
758 QUALITY OF LIFE DECREASED 34 0.0025
759 SEPSIS 282 0.0025
760 TINNITUS 116 0.0025
761 PRODUCT ADMINISTRATION ERROR 51 0.0025
762 THROMBOSIS 203 0.0025
763 UNDERDOSE 184 0.0025
764 DYSPHONIA 147 0.0025
765 TENDON RUPTURE 31 0.0025
766 CYTOKINE RELEASE SYNDROME 50 0.0025
767 SKIN EXFOLIATION 209 0.0025
768 ELECTROCARDIOGRAM QT PROLONGED 89 0.0025
769 MYOCARDIAL ISCHAEMIA 28 0.0025
770 INCONTINENCE 26 0.0025
771 FULL BLOOD COUNT ABNORMAL 26 0.0025
772 ATRIAL FIBRILLATION 239 0.0025
773 HYPERSOMNIA 70 0.0024
774 PRESYNCOPE 59 0.0024
775 RENAL DISORDER 113 0.0024
776 GINGIVAL BLEEDING 33 0.0024
777 BRADYCARDIA 128 0.0024
778 HYPOTHYROIDISM 77 0.0024
779 FEELING ABNORMAL 575 0.0024
780 OESOPHAGITIS 26 0.0024
781 GLYCOSYLATED HAEMOGLOBIN INCREASED 60 0.0024
782 LETHARGY 136 0.0024
783 PHOTOSENSITIVITY REACTION 39 0.0024
784 TACHYPNOEA 32 0.0024
785 ACCIDENT 28 0.0023
786 EYE PRURITUS 78 0.0023
787 INTESTINAL PERFORATION 26 0.0023
788 HAEMATOMA 60 0.0023
789 FISTULA 26 0.0023
790 HAEMORRHOIDS 45 0.0023
791 ABDOMINAL PAIN LOWER 58 0.0023
792 PSYCHOMOTOR HYPERACTIVITY 38 0.0023
793 INCORRECT PRODUCT ADMINISTRATION DURATION 49 0.0023
794 ANAEMIA 431 0.0023
795 PRODUCT PRESCRIBING ISSUE 49 0.0022
796 BLOOD GLUCOSE DECREASED 108 0.0022
797 PERICARDIAL EFFUSION 52 0.0022
798 BONE DENSITY DECREASED 70 0.0022
799 DIABETES MELLITUS 170 0.0022
800 OVERDOSE 479 0.0022
801 CORONARY ARTERY OCCLUSION 30 0.0022
802 DRUG INEFFECTIVE 2866 0.0022
803 RESPIRATORY DISTRESS 60 0.0022
804 ECZEMA 113 0.0022
805 HYPOKALAEMIA 99 0.0021
806 BLOOD CALCIUM DECREASED 24 0.0021
807 BEDRIDDEN 28 0.0021
808 MENTAL STATUS CHANGES 59 0.0021
809 SEIZURE 245 0.0021
810 GLOMERULAR FILTRATION RATE DECREASED 26 0.0021
811 TREMOR 351 0.0021
812 SPINAL OPERATION 26 0.0021
813 OCULAR HYPERAEMIA 100 0.0021
814 INTESTINAL OBSTRUCTION 79 0.0021
815 PRODUCT USE COMPLAINT 33 0.0021
816 BLOOD POTASSIUM INCREASED 34 0.0021
817 SWELLING FACE 136 0.0021
818 HYPOMAGNESAEMIA 29 0.0021
819 DIPLOPIA 54 0.0021
820 SUICIDE ATTEMPT 124 0.0020
821 SKIN LESION 56 0.0020
822 PNEUMONIA ASPIRATION 51 0.0020
823 ACUTE RESPIRATORY DISTRESS SYNDROME 36 0.0020
824 DEAFNESS 53 0.0020
825 MYALGIA 341 0.0020
826 BLOOD GLUCOSE ABNORMAL 37 0.0020
827 LOSS OF CONSCIOUSNESS 256 0.0020
828 ARRHYTHMIA 94 0.0020
829 OSTEOPENIA 30 0.0020
830 METABOLIC ACIDOSIS 63 0.0020
831 MOVEMENT DISORDER 63 0.0020
832 PAIN IN JAW 55 0.0019
833 PLATELET COUNT DECREASED 205 0.0019
834 PLEURAL EFFUSION 117 0.0019
835 LIP SWELLING 64 0.0019
836 FEBRILE NEUTROPENIA 127 0.0019
837 BLINDNESS 78 0.0019
838 LYMPHOPENIA 27 0.0019
839 DERMATITIS ALLERGIC 24 0.0019
840 THIRST 34 0.0019
841 GASTRIC ULCER 36 0.0019
842 CEREBROVASCULAR ACCIDENT 319 0.0019
843 THROMBOCYTOPENIA 210 0.0019
844 FEEDING DISORDER 38 0.0019
845 PERITONITIS 38 0.0018
846 SHOCK 42 0.0018
847 EPILEPSY 55 0.0018
848 RASH MACULO-PAPULAR 40 0.0018
849 PANIC ATTACK 65 0.0018
850 HAEMATURIA 61 0.0018
851 RESTLESSNESS 65 0.0018
852 GENERALISED TONIC-CLONIC SEIZURE 29 0.0018
853 DIABETES MELLITUS INADEQUATE CONTROL 31 0.0017
854 RASH PAPULAR 39 0.0017
855 BONE LOSS 26 0.0017
856 PRODUCT PRESCRIBING ERROR 41 0.0017
857 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 58 0.0017
858 ASCITES 50 0.0017
859 ACCIDENTAL OVERDOSE 62 0.0017
860 PULMONARY EMBOLISM 161 0.0017
861 URINARY INCONTINENCE 50 0.0017
862 CARDIAC ARREST 139 0.0017
863 SEDATION 44 0.0017
864 SPEECH DISORDER 88 0.0017
865 TRANSAMINASES INCREASED 37 0.0017
866 EYE IRRITATION 95 0.0016
867 TOOTH LOSS 34 0.0016
868 MYELOSUPPRESSION 59 0.0016
869 FOETAL EXPOSURE DURING PREGNANCY 132 0.0016
870 THINKING ABNORMAL 30 0.0016
871 POLLAKIURIA 67 0.0016
872 TRANSIENT ISCHAEMIC ATTACK 54 0.0016
873 COMA 75 0.0016
874 DERMATITIS 33 0.0016
875 UPPER GASTROINTESTINAL HAEMORRHAGE 26 0.0015
876 VISION BLURRED 211 0.0015
877 PULMONARY HYPERTENSION 32 0.0015
878 GAMMA-GLUTAMYLTRANSFERASE INCREASED 34 0.0015
879 HYPOCALCAEMIA 29 0.0015
880 HYPERGLYCAEMIA 55 0.0015
881 PNEUMONITIS 41 0.0015
882 HYPOGLYCAEMIA 73 0.0015
883 DEPRESSED LEVEL OF CONSCIOUSNESS 59 0.0015
884 DISORIENTATION 58 0.0015
885 LUNG NEOPLASM MALIGNANT 60 0.0015
886 NEUTROPENIA 198 0.0015
887 RESPIRATORY ARREST 40 0.0014
888 BLOOD GLUCOSE INCREASED 271 0.0014
889 CRYING 52 0.0014
890 MENTAL DISORDER 62 0.0014
891 ANGIOEDEMA 63 0.0014
892 RENAL IMPAIRMENT 119 0.0014
893 HAEMORRHAGE 148 0.0014
894 SWOLLEN TONGUE 44 0.0014
895 HEPATITIS 36 0.0014
896 ACUTE RESPIRATORY FAILURE 27 0.0014
897 DEEP VEIN THROMBOSIS 90 0.0014
898 SUICIDAL IDEATION 126 0.0014
899 DEMENTIA 38 0.0014
900 CORONARY ARTERY DISEASE 41 0.0014
901 SEROTONIN SYNDROME 26 0.0014
902 HYPONATRAEMIA 76 0.0013
903 HYPOACUSIS 58 0.0013
904 LIVER FUNCTION TEST ABNORMAL 39 0.0013
905 CEREBRAL HAEMORRHAGE 48 0.0013
906 FLATULENCE 76 0.0013
907 FULL BLOOD COUNT DECREASED 27 0.0013
908 CARDIO-RESPIRATORY ARREST 56 0.0013
909 DYSSTASIA 39 0.0013
910 DISTURBANCE IN ATTENTION 72 0.0013
911 SEPTIC SHOCK 58 0.0013
912 BONE PAIN 78 0.0013
913 DEVICE BREAKAGE 54 0.0013
914 DEVICE DISLOCATION 57 0.0013
915 MOOD ALTERED 35 0.0013
916 CARDIAC FAILURE CONGESTIVE 103 0.0013
917 SURGERY 74 0.0013
918 HEPATIC FUNCTION ABNORMAL 47 0.0013
919 INJECTION SITE SWELLING 96 0.0013
920 RESPIRATORY FAILURE 91 0.0012
921 PANCYTOPENIA 69 0.0012
922 HYPOPHAGIA 31 0.0012
923 DRY SKIN 160 0.0012
924 HALLUCINATION 90 0.0012
925 INCORRECT DOSE ADMINISTERED 267 0.0012
926 MULTIPLE ORGAN DYSFUNCTION SYNDROME 33 0.0012
927 ANAPHYLACTIC SHOCK 30 0.0012
928 ACNE 88 0.0012
929 THERAPEUTIC RESPONSE UNEXPECTED 52 0.0012
930 INJECTION SITE PRURITUS 77 0.0011
931 CARDIAC FAILURE 91 0.0011
932 IRRITABILITY 67 0.0011
933 FAECES DISCOLOURED 24 0.0011
934 HEPATIC FAILURE 33 0.0011
935 INTERNATIONAL NORMALISED RATIO INCREASED 31 0.0011
936 DYSKINESIA 44 0.0011
937 INJECTION SITE RASH 32 0.0010
938 TREATMENT NONCOMPLIANCE 57 0.0010
939 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 57 0.0010
940 HOSPITALISATION 159 0.0010
941 INJECTION SITE MASS 38 0.0010
942 DRUG RESISTANCE 26 0.0010
943 BLOOD CREATINE PHOSPHOKINASE INCREASED 29 0.0010
944 RHABDOMYOLYSIS 42 0.0010
945 RENAL FAILURE 132 0.0010
946 ANGER 33 0.0010
947 MULTIPLE SCLEROSIS RELAPSE 66 0.0010
948 INJECTION SITE ERYTHEMA 119 0.0010
949 DEVICE ISSUE 86 0.0010
950 MUCOSAL INFLAMMATION 25 0.0010
951 EXTRA DOSE ADMINISTERED 38 0.0009
952 NERVOUS SYSTEM DISORDER 29 0.0009
953 DISEASE RECURRENCE 42 0.0009
954 MYOCARDIAL INFARCTION 152 0.0009
955 DRUG INTERACTION 138 0.0009
956 ABNORMAL BEHAVIOUR 34 0.0009
957 ACUTE MYOCARDIAL INFARCTION 25 0.0008
958 BREAST CANCER 79 0.0008
959 INJECTION SITE BRUISING 67 0.0008
960 SKIN IRRITATION 38 0.0008
961 ABORTION SPONTANEOUS 33 0.0008
962 EMOTIONAL DISORDER 25 0.0008
963 DYSGEUSIA 60 0.0008
964 INJECTION SITE REACTION 55 0.0008
965 THERAPY INTERRUPTED 57 0.0008
966 DEATH 680 0.0008
967 WITHDRAWAL SYNDROME 33 0.0008
968 CHRONIC KIDNEY DISEASE 58 0.0008
969 GASTROINTESTINAL HAEMORRHAGE 61 0.0007
970 DEVICE LEAKAGE 31 0.0007
971 INJECTION SITE PAIN 218 0.0007
972 UNEVALUABLE EVENT 52 0.0007
973 DISEASE PROGRESSION 77 0.0007
974 PLASMA CELL MYELOMA 25 0.0006
975 RENAL CANCER 30 0.0006
976 VAGINAL HAEMORRHAGE 27 0.0006
977 EMOTIONAL DISTRESS 75 0.0006
978 ACUTE KIDNEY INJURY 90 0.0006
979 DEVICE MALFUNCTION 37 0.0005
980 AGGRESSION 26 0.0005
981 DERMATITIS ATOPIC 27 0.0005
982 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 95 0.0005
983 INJECTION SITE HAEMORRHAGE 37 0.0005
984 SKIN BURNING SENSATION 32 0.0004
985 PROSTATE CANCER 34 0.0004
986 CONVULSION 24 0.0004
987 MALIGNANT NEOPLASM PROGRESSION 36 0.0004
988 NO ADVERSE EVENT 58 0.0003
989 PRODUCT STORAGE ERROR 27 0.0003
990 PRODUCT QUALITY ISSUE 40 0.0003
991 DRUG WITHDRAWAL SYNDROME 25 0.0003
992 ACCIDENTAL EXPOSURE TO PRODUCT 28 0.0003
993 DRUG DEPENDENCE 40 0.0002